Acadia Pharmaceuticals Cannot Catch a Break With Quant Downgrade

Acadia Pharmaceuticals Cannot Catch a Break With Quant Downgrade
·2 min read

TheStreet's Quant Ratings service downgraded Acadia Pharmaceuticals to a "sell" Monday. But what do the technicals say? When we reviewed the ACAD charts on April 5 we wrote that, "It is not important where ACAD declines to the $16 area as suggested by the Point and Figure chart.